Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01508117
Title Phase II Axitinib (AG-013736) in Elderly Glioblastoma Multiforme (GBM) Patients
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Cincinnati
Indications
Therapies
Age Groups: senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Cincinnati Cincinnati Ohio 45267-0502 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field